PMID: 18732406Jun 1, 1961Paper

OTOTOXIC ANTIBIOTICS.

California Medicine
J L Sheehy

Abstract

Shortly after the introduction of streptomycin and dihydrostreptomycin in the treatment of tuberculosis, irreversible perceptive hearing losses were noted as a side effect. Although hearing loss became less of a problem when reduced dosage schedules were adopted, the more widespread use of these drugs, often in combinations with other antibiotics, in nontuberculous disease has caused an increase in hearing loss in the last few years. Neomycin and kanamycin share this ototoxic property. Widespread use of these drugs is resulting in loss of hearing in a significant number of cases.

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Gaceta médica de México
A de la Rosa-GálvezM Hernández-Goribar
Brazilian Journal of Otorhinolaryngology
Elizabeth Oliveira Crepaldi de AlmeidaIlmara Fátima de Moraes
© 2022 Meta ULC. All rights reserved